Mean frequency of premature ventricular complexes as predictor of malignant ventricular arrhythmias

Mount Sinai Journal of Medicine

Volumn 72, Issue 6, 2005, Pages 374-380

  Carrim, Zia I ^a,b   Khan, Ashraf A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Implantable cardioverter defibrillator; Premature ventricular complexes; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFIBRILLATOR; DISEASE SEVERITY; FATALITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; MALE; PREDICTION; RISK ASSESSMENT;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR PREMATURE COMPLEXES;

EID: 28044465971     PISSN: 00272507     EISSN: 00272507     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Roelke M, Garan H, McGovern BA, Ruskin JN. Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Coll Cardiol 1994; 23:117-122.
2. Saeed M, Link MS, Mahapatra S, et al. Analysis of intracardiac electrograms showing monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators. Am J Cardiol 2000; 85:580-587.
3. Bleiffer SB, Karpman HL, Sheppard JJ, Bleiffer DJ. Relation between premature ventricular complexes and development of ventricular tachycardia. Am J Cardiol 1973; 31:400-403.
4. Lown B. Sudden cardiac death. Circulation 1979; 60:1593-1599.
5. Lown B, Wolf MA. Approaches to sudden death from coronary heart disease. Circulation 1971; 44:130-142.
6. Lown B, Fakhro AM, Hood BW, Thorn G. The coronary care unit: new perspectives and directions. JAMA 1967; 199:188-198.
7. Lown B, Klein MD, Hershberg PI. Coronary and precoronary care. Am J Med 1969; 46:705-724.
8. Lawrie DM, Higgins MR, Godman MJ, et al. Ventricular fibrillation complicating acute myocardial infarction. Lancet 1968; 2:523-528.
9. Ryan M, Lown B, Horn H. Comparison of ventricular ectopic activity during 24 hour monitoring and exercise testing in patients with coronary heart disease. N Eng J Med 1975; 292:224-229.
10. Lown B, Calvert AF, Armington R, Ryan M. Monitoring for serious arrhythmias and high risk of sudden death. Circulation 1975; 52(Suppl III):189.
11. Calvert A, Lown B, Gorlin R. Ventricular premature beats and anatomically defined coronary heart disease. Am J Cardiol 1977; 39:627-634.
12. Lombardi F, Porta A, Marzegalli M, et al. Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Am J Cardiol 2000; 86:959-963.
13. Meyerfeldt U, Schirdewan A, Wiedemann M, et al. The mode of onset of ventricular tachycardia. Eur Heart J 1997; 18:1956-1965.
14. Auricchio A, Hartung W, Geller C, Klein H. Clinical relevance of stored electrograms for implantable cardioverter-defibrillator (ICD) troubleshooting and understanding of mechanisms for ventricular tachyarrhythmias. Am J Cardiol 1996; 78(Suppl 5A):33-41.
15. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Eng J Med 2001; 345:1473-1482.
16. Myerburg RJ, Interian A Jr, Mitrani RM, et al. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997; 80(5B):10F-19F.
17. Teerlink JR, Jalaluddin M, Anderson S, et al. Ambulatory Ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden cardiac death. Circulation 2000; 101:40-46.
18. Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure: Captopril-Digoxin study group. J Am Coll Cardiol 1989; 14:564-570.
19. Rouleau J, Shenasa M, de Champlain J, Nadeau R. Predictors of survival and sudden death in patients with stable severe congestive heart failure due to ischemic and nonischemic causes: a prospective long term study of 200 patients. Can J Cardiol 1990; 6(10):453-460.
20. Szabo BM, van Veldhuisen DI, Crijns HJ, et al. Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure. Eur Heart J 1994; 15:928-933.
21. Doval HC, Nul DR, Grancelli HO, et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation 1996; 94:3198-3203.
22. Maggioni AP, Zuanetti G, Franzosi MG et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era (GISSI-2 results). Circulation 1993; 87:312-322.
23. Nalos PC, Pappas JM, Nyitray W, et al. Prospective community evaluation of the signal-averaged electrocardiogram in predicting malignant ventricular arrhythmias: beneficial outcome with electrophysiology guided therapy. Clin Cardiol 1991; 14(12):963-970.
24. Breithardt G, Fetsch T, Reinhardt L, et al. [Ventricular late potentials - methods and clinical importance.] [German] Ther Umsch 1992; 49(8):550-558.
25. Breithardt G, Borggrefe M, Fetsch T, et al. Prognosis and risk stratification after myocardial infarction. Eur Heart J 1995; 16:10-19.
26. Steinberg JS, Regan A, Sciacca RR, et al. Predicting arrhythmic events after acute myocardial infarction using the signal averaged electrocardiogram. Am J Cardiol 1992; 69:13-21.
27. Kleiger RE, Miller JP, Biggar JT, Moss AJ; and The Multicenter Postinfarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59:256-262.
28. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk and intervention assessment. Ann Intern Med 1993; 119:1187-1197.
29. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Eng J Med 1983; 309:331-336.
30. Bigger JT, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69:250-258.
31. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992; 85(Suppl I):I2-I10.
32. Luu M, Stevenson WG, Stevenson LW, et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989; 80:1675-1680.
33. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992; 85(Suppl I):I50-I56.
34. Bigger JT. Role of left ventricular ejection fraction. In: Akhtar M, Myerburg RJ, Ruskin JN, editors, Sudden cardiac death. Philadelphia: Williams & Wilkins, 1994. pp. 190-201.
35. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Eng J Med 1996; 335:1933-1940.
36. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Eng J Med 1997; 337:1576-1583.
37. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial. N Eng J Med 1999; 341:1882-1890.
38. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure: Sudden Cardiac Death in Heart Failure Trial. N Eng J Med 2005; 352:225-237.
39. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction: Multicenter Automatic Defibrillator Implantation Trial II. N Eng J Med 2002; 346:877-883.
40. Wiggers CJ, Wegria R. Ventricular fibrillation due to single, localized induction and condenser shocks applied during the vulnerable phase of ventricular systole. Am J Physiol 1940; 128:500-505.
41. Myerburg RJ, Kessler KM, Bassett AL, Castellanos A. A biological approach to sudden cardiac death: structure function and cause. Am J Cardiol 1989; 63:1512-1516.
42. Caruso AC, Marcus FI, Hahn EA, et al. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Circulation 1997; 96:1888-1892.
43. Maggioni AP, Zuaneti G, Franzozi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation 1993; 87:312-322.
44. Ruberman W, Weinblatt E, Goldberg JD, et al. Ventricular premature complexes and sudden death after myocardial infarction. Circulation 1981; 64:297-305.
45. Grubb N, Stone N, Thornhill L, et al. Frequency of atrial premature beats in the pre-fibrillation period in patients with paroxysmal atrial fibrillation [abstract]. Heart 2001; 85(Suppl I):P10.
46. Echt DS, Liebson PR, Mitchell LB; and the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Eng J Med 1991; 324:781-788.
47. The Cardiac Arrhythmia Suppression Trial- II Investigators. Effect of the anti-arrhythmic agent moricizine on survival after myocardial infarction: Cardiac Arrhythmia Suppression Trial II. N Eng J Med 1992; 327:227-233.
48. Berger MD, Harvey L, Waxman M, et al. Spontaneous compared with induced onset of sustained ventricular tachycardia. Circulation 1988; 78:885-892.